title: Erythromycin administration before sleep is effective in decreasing fasting hyperglycemia in type 2 diabetic patients.
authors: N
authors: N
authors: Ueno
authors: A
authors: A
authors: Inui
authors: A
authors: A
authors: Asakawa
authors: F
authors: F
authors: Takao
authors: A
authors: A
authors: Ichibangase
authors: Y
authors: Y
authors: Komatsu
authors: M
authors: M
authors: Kasuga
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004334:Drug Administration Schedule; D004917:Erythromycin / Q000008:administration & dosage* / Q000627:therapeutic use; D005215:Fasting; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D012890:Sleep
chemical_list: D001786:Blood Glucose; D004917:Erythromycin; D005765:Gastrointestinal Agents; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin